Company intelligence
Bond Health
AI-platform improving clinical trial patient recruitment from patient identification, outreach, and onboarding.
About Bond Health
Leveraging proprietary LLMs to improve the efficiency and end-to-end tracking of the clinical trial patient recruitment process.
Verified activity
Signals from Bond Health
21 published signals
Research & Knowledge
Bond Health mapped all 455 clinical trials Eli Lilly has started in the last 5 years using ClinicalTrials(.)gov
Reported by Rishabh Goel
Research & Knowledge
Bond Health ranked Roche as the company with the most cancer trials actively recruiting patients right now.
Reported by Rishabh Goel
Research & Knowledge
Bond Health ranked Pfizer as the company with the most cancer trials actively recruiting patients right now.
Reported by Rishabh Goel
Research & Knowledge
Bond Health ranked Novartis as the company with the most cancer trials actively recruiting patients right now.
Reported by Rishabh Goel
Research & Knowledge
Bond Health ranked Merck as the company with the most cancer trials actively recruiting patients right now.
Reported by Rishabh Goel
Research & Knowledge
Bond Health ranked Johnson & Johnson as the company with the most cancer trials actively recruiting patients right now.
Reported by Rishabh Goel
Research & Knowledge
Bond Health ranked Innovent as the company with the most cancer trials actively recruiting patients right now.
Reported by Rishabh Goel
Research & Knowledge
Bond Health ranked Hengrui Pharma as the company with the most cancer trials actively recruiting patients right now.
Reported by Rishabh Goel
Research & Knowledge
Bond Health ranked Bristol Myers Squibb as the company with the most cancer trials actively recruiting patients right now.
Reported by Rishabh Goel
Research & Knowledge
Bond Health ranked AstraZeneca as the company with the most cancer trials actively recruiting patients right now.
Reported by Rishabh Goel
Research & Knowledge
Bond Health ranked Akeso as the company with the most cancer trials actively recruiting patients right now.
Reported by Rishabh Goel
Research & Knowledge
Bond Health found that Sanofi had 20 percent of its clinical trials terminated.
Reported by Rishabh Goel
Research & Knowledge
Bond Health found that Roche had 20 percent of its clinical trials terminated.
Reported by Rishabh Goel
Research & Knowledge
Bond Health found that Novartis had 15 percent of its clinical trials terminated.
Reported by Rishabh Goel
Research & Knowledge
Bond Health found that Merck had 15 percent of its clinical trials terminated.
Reported by Rishabh Goel
Research & Knowledge
Bond Health found that Johnson & Johnson had 21 percent of its clinical trials terminated.
Reported by Rishabh Goel
Research & Knowledge
Bond Health found that Eli Lilly had 9 percent of its clinical trials terminated.
Reported by Rishabh Goel
Research & Knowledge
Bond Health found that Bristol Myers Squibb had 14 percent of its clinical trials terminated.
Reported by Rishabh Goel
Research & Knowledge
Bond Health found that AstraZeneca had 14 percent of its clinical trials terminated.
Reported by Rishabh Goel
Research & Knowledge
Bond Health found that Amgen had 17 percent of its clinical trials terminated.
Reported by Rishabh Goel
Research & Knowledge
Bond Health analyzed every terminated clinical trial by lead sponsor and looked at what share stopped because they could not enroll enough patients.
Reported by Rishabh Goel